KarinCA

Long only, biotech, small-cap, micro-cap
KarinCA
Long only, biotech, small-cap, micro-cap
Contributor since: 2012
David Jackson, Contributor
long/short equity, tech, ETF investing
Dirk Leach, Contributor
long only, dividend investing, dividend growth investing, energy
Full-time Investor, Developed International Markets, Dividend stock ideas & income
JKenser, Contributor
long/short equity, biotech, small-cap
Mitch Nolen, Contributor
online retail, brick & mortar retail, eCommerce
David Sims, Contributor
long/short equity, special situations, activist investor
Glen Bradford, Contributor
value, growth at reasonable price, long-term horizon, portfolio strategy
Dividend House, Contributor
dividend growth investing, long only
Albert Alfonso, Contributor
dividend investing, dividend growth investing, master limited partnerships, oil & gas
Chuck Carnevale, Contributor
long/short equity, growth, dividend growth investing
Nicholas Pardini, Contributor
contrarian, macro, hedge fund manager, emerging markets
Karin Hernandez, Contributor
Occasional Investor, Dividend stock ideas & income, Energy stocks
Pharma Doc, Contributor
long/short equity, event-driven, biotech, healthcare
long only, growth at reasonable price, value, research analyst
Full-time Investor, Dividend stock ideas & income, Gold
Qwest Invests, Contributor
newsletter provider, event-driven, long/short equity
Netwall, Contributor
hedge fund manager, value, contrarian
David Fish, Contributor
value, long-term horizon, dividend investing, dividend growth investing
Paulo Santos, Contributor
long/short equity, arbitrage, event-driven, research analyst
Matija Snuderl, Contributor
small-cap, biotech, healthcare, growth
value, special situations, small-cap, registered investment advisor
Jim Bowie, Contributor
small-cap, biotech, healthcare
SA PRO Editors, Contributor
Full-time Investor, Stocks - long, Stocks - short
Todd Johnson, Contributor
closed-end funds, dividend investing, REITs, newsletter provider
Chris Lau, Contributor
contrarian, event-driven, tech, oil & gas
Clay King, Contributor
growth at reasonable price, value, contrarian, dividend investing
Sharon di Stefano, Contributor
biotech, healthcare, small-cap, special situations